The Royal college of Surgeons in Ireland, in accordance with the Environmental Protection Agency’s Guidelines for Research Involving Recombinant DNA Molecules, has established an Institutional Biosafety Committee (IBC) to oversee research that involves Recombinant DNA, Infectious Agents and toxins at this institution.
All researchers (faculty, staff, students) or users of the facilities at RCSI who are currently using or contemplating use of recombinant DNA research must comply with these Guidelines. All protocols, in which recombinant DNA will be used, regardless of the funding source, must be submitted to the Institutional Biosafety Committee for review.
The following document and form to be reviewed and completed for all Biological Agent work:
| Risk Assessment Procedure |
| Risk Assessment Template – General |
| Genetically Modified Biological Agents Risk Assessment – Template |
| RCSI Biosafety Risk Assessment COVID-19-Template |
For additional information please see the Institutional Biosafety Committee page or contact Dr. Steve Kerrigan, Chair Institutional Biosafety Committee. Email: biosafety@rcsi.ie